Biotech

Startups News

Biotech Startups Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech

Top news of the week: 12.04.2022.

#biotech
#unicorn
#venture
#NBTintheNews
#Startup

Startups

@MikeNGladstone shared
On Apr 7, 2022
RT @LifeSciVC: "Take the Hors D’oeuvres When They’re Passed And Other Life Lessons From An “Old” CEO"... Natalie Holles, CEO of @3rdHarmonicBio, shares her reflections on #biotech leadership in her debut From The Trenches blog. @NatalieHolles https://t.co/w3szXnNTQA
Open
Take the Hors D’oeuvres When They’re Passed And Other Life Lessons From An “Old” CEO

Take the Hors D’oeuvres When They’re Passed And Other Life Lessons From An “Old” CEO

By Natalie Holles, CEO of Third Harmonic Bio, as part of the From The Trenches feature of LifeSciVC Our company recently launched out of stealth with a trade media campaign in the usual ...

@CBinsights shared
On Apr 7, 2022
New: after a red-hot 2021, global #venture investment cooled in Q1’22, even as the global #unicorn club reaches a new high. Here's everything you need to know: https://t.co/vjyYnh1KQj
Open
State of Venture Q1’22 Report

State of Venture Q1’22 Report

After a red-hot 2021, global venture investment cools in Q1’22, even as the global unicorn club reaches a new high.

@BentheFidler shared
On Apr 6, 2022
Regeneron, in search of an eye gene therapy, turns to a young biotech https://t.co/vV1U9ll8AV by @realJacobBell $REGN $BIIB
Open
Regeneron, in search of an eye gene therapy, turns to a young biotech

Regeneron, in search of an eye gene therapy, turns to a young biotech

Facing mounting competition to its top-selling drug Eylea, Regeneron is teaming up with ViGeneron to develop a genetic medicine for an inherited retinal disease.

@ReutersBiz shared
On Apr 6, 2022
Harry Sloan, Jeff Sagansky scrap IPO plans for SPAC venture https://t.co/3hNoSN9epj https://t.co/qg5LMDJdLG
Open
Harry Sloan, Jeff Sagansky scrap IPO plans for SPAC venture

Harry Sloan, Jeff Sagansky scrap IPO plans for SPAC venture

Blank-check firm Spinning Eagle Acquisition Corp, backed by former Hollywood executives Harry Sloan and Jeff Sagansky, on Wednesday filed to withdraw its U.S. initial public offering of up ...

@NatureBiotech shared
On Apr 7, 2022
@lifebiosciences @turn_bio @newlimit @RetroBio_ @agexthera @harvardstemcell @BiologyAgeing Scientists used cellular rejuvenation therapy to rewind aging in mice #NBTintheNews via @singularityhub https://t.co/8PO4FeudVX
Open
Scientists Used Cellular Rejuvenation Therapy to Rewind Aging in Mice

Scientists Used Cellular Rejuvenation Therapy to Rewind Aging in Mice

Yamanaka factors regulate DNA expression, erasing a cell’s epigenetic landscape and transforming grown cells back into an embryonic state.

@Forbes shared
On Apr 8, 2022
China Investment In U.S. To Remain Low Amid Pandemic, Invasion Fallout: Rhodium Group https://t.co/3EYhV6OzsK https://t.co/hgL3YrM3Ej
Open
China Investment In U.S. To Remain Low Amid Pandemic, Invasion Fallout: Rhodium Group

China Investment In U.S. To Remain Low Amid Pandemic, Invasion Fallout: Rhodium Group

Mainland businesses' approach in U.S. begins to mirror that of U.S. companies in China

@big4bio shared
On Apr 11, 2022
RT @biostartupnews: California Life Sciences Expands #Startup Commercialization Program to SoCal Hubs California Life Sciences (@CALifeSciences ), the state’s life sciences membership organization, is expanding its acclaimed FAST Advisory program https://t.co/DooU6GyrSO
Open
California Life Sciences Expands Startup Commercialization Program to SoCal Hubs

California Life Sciences Expands Startup Commercialization Program to SoCal Hubs

California Life Sciences (CLS), the state’s life sciences membership organization, is expanding its acclaimed FAST Advisory program for life science startups to Southern California. FAST ...

@PitchBook shared
On Apr 7, 2022
RT @mcelarier: My latest on SPACs: Companies That Merged With SPACs Have Underperformed the S&P 500 by a Stunning Margin Since 2018 https://t.co/OALzyWWE7K via @iimag
Open
Companies That Merged With SPACs Have Underperformed the S&P 500 by a Stunning Margin Since 2018

Companies That Merged With SPACs Have Underperformed the S&P 500 by a Stunning Margin Since 2018

At no time during the recent SPAC boom — except for a few days in early 2021 — did these new listings beat the S&P.

Read more: Startups
weekly 12.04.2022
View archives
Back to home

Subscribe to Biotech - Startups.

Avoid an information overload and get the most trusted industry news hand-picked by the top Experts. Sign up for the weekly Biotech - Startups.
Privacy Policy

Sign up for the weekly Biotech - Startups newsletter

Never again miss anything or anyone that matter in Biotech

Sign up and receive the Biotech - Startups weekly email newsletter directly to your inbox. Make more informed business decisions based on insight for the most trusted industry experts, faster.
Privacy Policy